Latest News about VTRS
Recent news which mentions VTRS
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
April 21, 2025
From Benzinga
From Motley Fool
Viatris Agrees To $335 Million Opioid Settlement Framework
April 07, 2025
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
April 04, 2025
From Benzinga
Tesla, Palantir And MicroStrategy Are Among Top 12 Large-Cap Losers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
March 02, 2025
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
From Benzinga
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
January 06, 2025
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
From Benzinga
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
November 07, 2024
From Benzinga
Generic Drugmaker Viatris Beats Expectations In Q3, CEO Praises $2 Billion Debt Paydown
November 07, 2024
From Benzinga
These 10 Stocks Were S&P 500's Worst Performers In Biden's First Year: Could Trend Continue If Harris Wins 2024 Election?
November 02, 2024
From Benzinga
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?
September 24, 2024
From Benzinga
EXCLUSIVE: Options Expert Warns Of 'Terrible Week' After Friday's Triple Witching
September 20, 2024
From Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
September 06, 2024
From Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
September 06, 2024
From Benzinga
3 Top Value Stocks to Buy Right Now
August 20, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
From Benzinga
US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs
August 08, 2024
From Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
From Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
July 26, 2024
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Tickers
VTRS
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.